Paula Abola | Pharmacology | Editorial Board Member

Mrs. Paula Abola | Pharmacology | Editorial Board Member

PhD Student and Professor | University of Jamestown | Germany

Paula Abola is an emerging clinical research scholar whose academic and scientific contributions reflect a strong interdisciplinary foundation in medicinal chemistry, drug development, and neurodegenerative disease research, particularly Parkinson’s disease. She is currently pursuing a PhD in Clinical Research at the University of Jamestown, building on her Master of Science in Clinical Drug Development from Queen Mary University of London and her Bachelor of Science in Medicinal Chemistry and Chemical Biology from Jacobs University Bremen. Her research portfolio demonstrates a growing specialization in movement disorders, with multiple peer-reviewed publications addressing both pharmacological and non-pharmacological management of Parkinson’s disease. Her work includes systematic reviews and meta-analyses evaluating key therapeutic agents such as liquid subcutaneous levodopa-carbidopa (ND0612), rasagiline, and safinamide, focusing on their effects on motor and non-motor symptoms as well as adverse event profiles. Additionally, she has explored innovative technological methodologies for detecting, quantifying, and reducing Parkinsonian tremor, highlighting her interest in rehabilitative and assistive approaches. Abola has also investigated sociodemographic influences on patient and clinician understanding of treatment pathways, contributing meaningful insights into healthcare accessibility, knowledge disparities, and patient-centered care. Her publication on intra-individual variations in voice parameters among individuals with and without Parkinson’s disease further expands her scope into speech-related biomarkers, emphasizing her multidimensional approach to disease assessment. Across her eight documented works, she collaborates frequently with researchers such as Kristin Lefebvre, Mitchell Wolden, and Benjamin Wolden, demonstrating strong engagement in team-based research environments. Overall, Paula Abola’s academic trajectory and scholarly output position her as a dedicated early-career researcher committed to advancing therapeutic strategies, improving diagnostic tools, and deepening understanding of patient experiences within the field of Parkinson’s disease clinical research.

Profile: ORCID

Featured Publications

  1. Abola, P., Lefebvre, K., & Wolden, M. (2025). Influence of sociodemographic variables on patient and practitioner knowledge of pharmacological management options for Parkinson’s disease. American Journal of Medical and Clinical Research & Reviews, 2025.

  2. Abola, P., Lefebvre, K. (2025). Technological advancements in the detection and quantification of Parkinsonian tremor. Topics in Geriatric Rehabilitation, July 2025.

  3. Abola, P., Wolden, M. (2025). Intra-individual variations in voice variables among individuals with and without Parkinson’s disease. Cureus, March 29, 2025.

  4. Abola, P., Wolden, M., & Lefebvre, K. (2024). Liquid subcutaneous levodopa-carbidopa ND0612 effects on motor symptoms in individuals with Parkinson’s disease: A systematic review and meta-analysis. Advances in Parkinson’s Disease, 2024.

  5. Abola, P., Wolden, M. (2024). Monoamine oxidase-B inhibitor rasagiline effects on motor and non-motor symptoms in individuals with Parkinson’s disease: A systematic review and meta-analysis. Advances in Parkinson’s Disease, 2024.

Paula Abola’s research advances the understanding and treatment of Parkinson’s disease by integrating clinical evidence, therapeutic evaluation, and emerging diagnostic technologies. Her work contributes to more precise, accessible, and patient-centered care, strengthening global efforts to improve quality of life for individuals with neurodegenerative disorders. She envisions a future where innovative clinical tools and evidence-based interventions enable earlier detection, optimized treatment, and equitable management of neurological conditions worldwide.

Mukesh Ratnaparkhi | Pharmacology | Best Researcher Award

Dr. Mukesh Ratnaparkhi | Pharmacology | Best Researcher Award 

Professor | Marathwada Mitramandals College of Pharmacy | India

Dr. Mukesh P. Ratnaparkhi, a distinguished pharmaceutical scientist with over 19 years of academic and research experience, demonstrates strong suitability for a Best Researcher Award through his extensive contributions to pharmaceutics, drug delivery systems, and formulation science. Currently serving as a Professor in Pharmaceutics at Marathwada Mitra Mandal’s College of Pharmacy, Pune, he has progressed through roles of increasing responsibility and is an approved Associate Professor, postgraduate teacher, and Ph.D. research guide under Savitribai Phule Pune University. His academic foundation includes a Ph.D. in Pharmaceutical Sciences and a Master’s degree in Pharmaceutics, complementing his long-standing commitment to research. Dr. Ratnaparkhi has an impressive research portfolio with 74 publications in reputed Scopus, Web of Science, UGC Care, and international indexed journals, addressing critical pharmaceutical challenges such as solubility enhancement, nanoformulations, targeted pulmonary delivery, nasal drug delivery, and advanced drug dispersion techniques. His work spans nanosponge systems, nanoemulgels, cubosomes, solid dispersions, and dry powder inhalation formulations, signifying his expertise in innovative and translational drug delivery approaches. He holds four patents (three granted and one filed), demonstrating originality and innovation, and has guided or collaborated on numerous research projects. Complementing his publication record, he has delivered 31 scientific presentations at national and international conferences, showcasing the continued relevance and impact of his research. His professional strengths include excellent communication, leadership, team management, and a strong research orientation, supported by early industrial training that broadened his practical understanding of pharmaceutical processes. With nearly two decades of academic service, consistent research productivity, significant innovation, mentorship roles, and contributions that influence modern drug delivery systems, Dr. Ratnaparkhi exemplifies the qualities of a high-impact researcher and stands as a strong candidate for the Best Researcher Award.

Featured Publications

  1. Ratnaparkhi, M. P., & Suryawanshi, A. N. (2025). Development and characterization of novel cilnidipine-loaded nanosponge formulations. International Journal of Drug Delivery Technology, 15(3), 1198–1204.

  2. Kshirsagar, S. D., & Ratnaparkhi, M. (2025). Formulation and evaluation of propolis loaded nanosponges based topical anti-inflammatory gel. Indian Journal of Pharmaceutical Education and Research, 59(4), 1–11.

  3. Tekade, A., Ratnaparkhi, M., Shewale, A., Shinde, R., Kulkarni, G., & Pawar, P. (2025). Design and assessment of in situ nasal gel incorporated with nanostructured cubosomes for the targeted therapy of schizophrenia. Journal of Research in Pharmacy, 29(3), 947–958.

  4. Ratnaparkhi, M., Binawade, B., Salvankar, S., Aswar, M., Jadhav, P., Parhad, P., Bhangare, S., & Dalvi, S. (2025). Intravaginal administration of metformin HCl loaded nanoemulgel for treatment of PCOS: In-vitro and in-vivo study. Brazilian Journal of Pharmaceutical Sciences.

  5. Ratnaparkhi, M. P., Tekade, A. R., Salvankar, S. S., Dalvi, S. D., Kulkarni, G. M., & Markand, M. G. (2025). RP-HPLC method development and validation for the quantification of remdesivir IV formulation. Indian Drug, 62(6), 45–49.

Dr. Ratnaparkhi’s research advances innovative drug-delivery systems that enhance therapeutic efficiency and patient outcomes. His work contributes to modern pharmaceutical science by translating nanotechnology-based formulations into practical healthcare solutions with global impact.

Dilek Soylu | Health Professions | Best Researcher Award

Assoc. Prof. Dr. Dilek Soylu | Health Professions | Best Researcher Award 

Academician | Kahramanmaraş Sütçü İmam Universty | Turkey

Assoc. Prof. Dr. Dilek Soylu is a highly accomplished academic whose extensive contributions to surgical nursing, organ transplantation, disaster preparedness, palliative care, and innovative nursing education make her an exceptional candidate for a Best Researcher Award. With a PhD in Surgical Nursing from Erciyes University and strong foundational training through both thesis and non-thesis master’s programs, she has built a career that integrates rigorous scientific inquiry with over a decade of hands-on clinical experience as an organ transplant coordinator and surgical intensive care nurse. This dual perspective strengthens the clinical applicability and societal relevance of her research. Assoc. Prof. Dr. Soylu has an impressive publication portfolio featuring numerous peer-reviewed international articles in respected journals including The Surgeon, BMC Nursing, Scandinavian Journal of Caring Sciences, Journal of PeriAnesthesia Nursing, and Transplant Immunology, exploring vital themes such as organ donation determinants, anxiety and pain management, acupressure interventions, disaster response self-efficacy, and transplant readiness scale development. Her scholarly activity spans mixed-methods studies, randomized controlled trials, descriptive analyses, retrospective research, and methodological scale development, demonstrating her scientific range and depth. She has presented widely at national and international conferences, authored book chapters, and engaged actively in professional organizations such as Türk Hemşireler Derneği and Organ Nakli Hemşireleri Derneği. Additionally, she has contributed to academic governance as Vice Director of the School of Health and served as a thesis jury member at multiple universities. Her diverse teaching portfolio includes courses in surgical nursing, emergency care, transplantation nursing, and nursing education, reflecting her commitment to shaping future generations of healthcare professionals. Ongoing research projects, including technology-enhanced training for nursing students and clinical intervention studies, further emphasize her forward-looking vision. With her strong research productivity, scholarly influence, leadership roles, and clear contributions to nursing science and healthcare improvement, Assoc. Prof. Dr. Dilek Soylu is highly suitable and deserving of recognition through a Best Researcher Award.

Profiles: ORCID | Scopus | ResearchGate

Featured Publications

  1. Soylu, D., & Doğaner, A. (2025). The effect of self-confidence, life satisfaction and death anxiety on organ donation in student nurses: Moderator effect. The Surgeon, 23.

  2. Soylu, A., Seven, A., & Soylu, D. (2025). The impact of training using six thinking hats versus video training on nursing students’ insulin administration skills: A mixed-methods study. BMC Nursing, 24.

  3. Soylu, A., & Soylu, D. (2025). Comparison of pain, anxiety, and comfort level after femoral or transradial angiography: A descriptive study. Journal of PeriAnesthesia Nursing.

  4. Soylu, D., & Soylu, A. (2025). Determination of urinary system infections risk factors after kidney transplantation: Retrospective analysis. Göbeklitepe Sağlık Bilimleri Dergisi, 9(19), 1–7.

  5. Soylu, D. (2025). Self-confidence, communication skills, and a solution-focused approach in organ transplantation coordinators: Descriptive study. Turkish Journal of Surgery, 41(1), 47–55.

Assoc. Prof. Dr. Dilek Soylu’s research advances science and society by strengthening evidence-based practices in surgical nursing, organ transplantation, disaster readiness, and patient-centered care. Her contributions enhance global healthcare quality through innovative training methods, clinical interventions, and multidisciplinary approaches that improve patient outcomes and professional competency. Her work continues to inspire transformative innovation across health professions and contributes meaningfully to the future of global healthcare systems.

Rabab Hassan Elshaikh Mahmoud | Health Professions | Best Researcher Award

Dr. Rabab Hassan Elshaikh Mahmoud | Health Professions | Best Researcher Award 

Assistant Professor | A’Sharqiyah University | Oman

Dr. Rabab Hassan Elshaikh is a highly accomplished medical laboratory scientist and academic with over 18 years of progressive experience spanning university teaching, clinical laboratory practice, research, and quality management. She holds a Ph.D. in Medical Laboratory Science (Hematology) and advanced qualifications including a Mini MBA and a professional diploma in laboratory quality and safety. Currently serving as an Assistant Professor at A’Sharqiyah University in Oman, she has previously held academic, supervisory, and specialist roles in top institutions across Sudan, UAE, and Oman. Dr. Rabab has significant expertise across hematology, immunohematology, immunology, microbiology, clinical chemistry, molecular diagnostics, and blood banking, supported by extensive technical experience on advanced analyzers and PCR platforms. She has published more than 20 research papers and book contributions in reputable international journals covering hematology, genetics, autoimmune disorders, infectious diseases, and personalized medicine, including studies on β-thalassemia, hemoglobinopathies, and AI-driven diagnostics. She has served as a reviewer for multiple scientific journals, contributed to conference presentations including a prestigious poster presentation at the European School of Hematology in Ireland, and earned a best paper award in 2025. Her professional credentials include international licenses (ASCPi, MOH UAE, DHA, SCFHS), memberships in global scientific organizations, and participation in accreditation and quality programs (ISO-15189, CAP, JCI, Lean Six Sigma). She has demonstrated strong leadership through developing SOPs, quality systems, training programs, and laboratory administration processes, ensuring compliance and excellence in service delivery. With broad clinical, academic, and research achievements, a strong publication record, and a commitment to advancing laboratory medicine and hematology, Dr. Rabab is exceptionally well-qualified and stands as an outstanding candidate for a Best Researcher Award and recognition in her field.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate

Featured Publications

Sah, A. K., Afzal, M., Elshaikh, R. H., Abbas, A. M., Shalabi, M. G., Prabhakar, P. K., Babker, A. M. A., Khalimova, F. T., Sabrievna, V. A., & Choudhary, R. K. (2025). Innovative strategies in the diagnosis and treatment of liver cirrhosis and associated syndromes. Life, 15(5), 779.

Elshaikh, R. H., Sah, A. K., Abukanna, A. M. A., Algarni, A., Abdelmola, A., Osma, H. A., & Alfeel, A. H. (2025). Mentzer index and red cell distribution width index in differentiating iron deficiency anemia and beta-thalassemia trait. Italian Journal of Medicine.

Sah, A. K., Elshaikh, R. H., Shalabi, M. G., Abbas, A. M., Prabhakar, P. K., Babker, A. M. A., Choudhary, R. K., Gaur, V., Choudhary, A. S., & Agarwal, S. (2025). Role of artificial intelligence and personalized medicine in enhancing HIV management and treatment outcomes. Life, 15(5), 745.

Rao, D. S., Kumar, A., Agarwal, S., Elshaikh, R. H., Choudhary, A., Choudhary, R. K., Babker, A. M. A., Rathore, R., Nurmakhanova, Z., & Nurgaliyeva, Z. (2025). The role of genetic variations in metabolic syndrome: Insights into etiology, diagnosis, and management. Italian Journal of Medicine, 19(1).

Hussein, A. H., Elsayed Yousif, T. Y., Abdelmola, A., Kumar, P., Osman, H. A., Elshaikh, R. H., Saboor, M., Hussein, S. O., Ali, E. I., & Elbashir, I. (2025). Prevalence and demographic analysis of hemoglobinopathies in newborns: A three-year study at Thumbay Teaching Hospital, Ajman-UAE. Journal of Blood Medicine, 16, 123-134.

The nominee’s visionary work catalyzes meaningful change across science, industry, and society by addressing critical global challenges. Their contributions expand the frontier of innovation, advance emerging technologies, and create pathways for sustainable economic and social development worldwide.

Purusharth Kumar Sharma | Medicine and Dentistry | Best Researcher Award

Dr. Purusharth Kumar Sharma | Medicine and Dentistry | Best Researcher Award

Doctor | Rajasthan Dental College and Hospital | India

Dr. Purusharth Kumar Sharma is an accomplished researcher and dental professional currently pursuing his Master of Dental Surgery at Rajasthan Dental College & Hospital, Nirwan University, Jaipur, India. He has made significant contributions to medical and dental research through multiple patents, including devices for parotid tumor removal, pain level detection in dental procedures, and advanced MRI scanning for enhanced soft tissue imaging. His published books cover interdisciplinary innovations linking dentistry, neurology, and cardiology. Dr. Sharma’s research work focuses on cardiovascular diseases, cancer, and oral health, with numerous presentations at prestigious national and international conferences such as IISc Bangalore and Jawaharlal Nehru University. His scholarly impact is demonstrated by 146 Google Scholar citations, an h-index of 6, and i10-index of 6. He has received multiple awards, including the Best Paper Award for glioblastoma research and the Certificate of Excellence for cardiovascular disease prevention studies. He has earned over 40 national and international certifications, including from Stanford University, American Heart Association, Royal College of Physicians (Edinburgh and London), American College of Cardiology, and European medical boards. He holds memberships in more than 30 prestigious medical and research associations such as ACC, AHA, ESC, UNESCO, AACR, and ISCP. His publication record spans reputed journals, including Indian Heart Journal and the Journal of Cardiovascular Medicine and Therapeutics, with contributions in atherosclerosis, cardiac arrest, and drug compound development for long QT syndrome and glioblastoma. Additionally, his editorial board memberships and academic engagement reflect a strong commitment to research dissemination and knowledge advancement. With his extensive multidisciplinary achievements, active research output, international collaborations, and academic leadership, Dr. Purusharth Kumar Sharma demonstrates strong suitability for recognition as a Best Researcher Award recipient.

Profile: Google Scholar

Featured Publications

Sharma, P. K. (2019). Atherosclerosis. International Journal of Biotechnology and Biomedical Sciences, 5(1), 75–75. Krishi Sanskriti Publications.

Sharma, P. K. (2020). Cardiac arrest. International Journal of Basic and Applied Biology, 7(1), 53–53. Krishi Sanskriti Publications.

Sharma, P. K. (2020). Atherosclerosis. Journal of the Association of Physicians of India, 68(1), 56.

Sharma, P. K. (2024). Composition of new compound for the treatment of Long QT Syndrome. Indian Heart Journal, 76(Supplement 2), S27.

Sharma, P. K. (2024). Composition of drug compound for glioblastoma. International Journal of Medicine.

Dr. Yong Yang | Medicine and Dentistry | Best Researcher Award

Dr. Yong Yang | Medicine and Dentistry | Best Researcher Award

Epidemiologist at Singapore General Hospital, Singapore

Dr. Yang Yong is an accomplished epidemiologist and public health researcher with extensive expertise in infection prevention, clinical epidemiology, and healthcare management. Holding a Ph.D. in Microbiology and an MSc in Clinical Science from the National University of Singapore, he has led and contributed to numerous national and international research projects, including clinical trials and epidemiological investigations on infectious diseases, tuberculosis, sepsis, and chronic conditions. His prolific publication record in reputed journals, research grants, and conference presentations reflect his scientific impact, while his leadership roles at Singapore General Hospital and Duke-NUS highlight his commitment to advancing medical science and mentoring future researchers. Recognized with multiple research awards, Dr. Yang continues to influence healthcare policy, quality improvement, and education, making him a strong candidate for the Best Researcher Award.

Professional Profile

Scopus Profile

Education

Dr. Yang Yong possesses a strong academic foundation with a BMed and MMed from Shanxi Medical University, followed by advanced studies in Singapore. He completed his Master of Clinical Science at the National University of Singapore and later earned a Ph.D. in Microbiology from the same institution, establishing his expertise in infectious diseases and epidemiology. His academic journey reflects a consistent focus on clinical research and public health, supported by additional training in project management, biostatistics, epidemiological research, and advanced imaging analysis techniques. Through continuous professional development courses across Singapore and internationally, Dr. Yang has strengthened his skills in research design, medical data analysis, and healthcare policy development. His educational background has provided a robust platform for his distinguished career in medical research, teaching, and clinical epidemiology.

 Experience

Dr. Yang Yong has built an impressive professional career spanning academia, clinical research, and hospital leadership. He has served as Epidemiologist and Director of the Department of Epidemiology at Singapore General Hospital, contributing to infection prevention, outbreak surveillance, and healthcare policy. In addition, he has held academic appointments as Adjunct Assistant Professor at Duke-NUS Graduate Medical School, where he co-mentored research students and participated in curriculum review. His early career included research fellowships at Tan Tock Seng Hospital and the National Neuroscience Institute, where he worked on HIV, neurology, and infectious disease projects. He also served as Honorary Academic Advisor at the Public TCM Research and Development Centre in Singapore. With decades of leadership, clinical, and academic service, Dr. Yang has consistently advanced medical science and healthcare practices through research, mentorship, and policy implementation.

Research Interest

Dr. Yang Yong’s primary research interests lie in infectious diseases, epidemiology, and public health, with a focus on hospital-acquired infections, tuberculosis, sepsis, and chronic conditions such as diabetes and autoimmune diseases. He has conducted extensive studies on methicillin-resistant Staphylococcus aureus, venous thromboembolism, and viral infections, contributing to better understanding of risk factors, treatment outcomes, and healthcare burden. His research extends to clinical epidemiology of HIV, body composition changes, and the application of advanced imaging technologies in disease monitoring. Dr. Yang has also investigated occupational health, stress biomarkers, and healthcare system quality improvement. His multidisciplinary approach integrates clinical practice, epidemiological modeling, and public health strategies, bridging gaps between patient care, infection control, and policy-making. His ongoing interests aim at strengthening infection prevention systems and advancing evidence-based healthcare delivery.

Awards and Honors

Dr. Yang Yong has received several prestigious awards that highlight his contributions to research and healthcare. He was honored with Best Poster Awards at the SingHealth Duke-NUS Scientific Congress in recognition of his research on venous thromboembolism and methicillin-resistant Staphylococcus aureus infections. Earlier in his career, he earned the Singapore General Hospital Gold Award for improving physician compliance with clinical guidelines. His academic achievements were further recognized through research scholarships at the National University of Singapore and the National Scholarship Council in China. These honors reflect his excellence in scientific inquiry, dedication to healthcare advancement, and contributions to medical education. His recognition at both institutional and international levels underscores the significance of his work in shaping clinical epidemiology and improving patient care outcomes.

Research Skill

Dr. Yang Yong demonstrates advanced research skills across clinical epidemiology, infectious disease research, and statistical analysis. He has extensive experience in designing and managing large-scale hospital-based studies, applying SPSS, STATA, and database systems such as ACCESS for complex data analysis. His expertise includes advanced MRI and imaging analysis, body composition measurement techniques, and biomarker evaluation for infectious and chronic diseases. He has successfully led and co-investigated numerous funded projects, including international clinical trials, epidemiological studies, and quality improvement initiatives. In addition, Dr. Yang possesses strong teaching and mentoring skills, having trained medical students, researchers, and clinicians in research methodology and statistical applications. His ability to translate scientific findings into healthcare policy and clinical practice demonstrates his capacity to bridge research, education, and real-world impact effectively.

Publication Top Notes

Title: The burden of methicillin-resistant Staphylococcus aureus infections among hospitalised patients in Singapore
Authors: Yang Y, Ling ML, Østbye T, Tan SB, Earnest A, Ng HS
Year: 2019
Citation: Revista Eletronica Gestao & Sociedade. 13(34): 2650–65

Title: A Report of Adult Human Adenovirus Infections in a Tertiary Hospital
Authors: Kalimuddin S, Chan YFZ, Wu IQ, Tan QL, Murthee KG, Tan BH, Oon LLE, Yang Y, Lin RTP, Joseph U, Sessions OM, Smith GJD, Ooi EE, Low JGH
Year: 2017
Citation: Open Forum Infect Dis. 4(2): ofx053. doi: 10.1093/ofid/ofx053. eCollection 2017 Spring

Title: The risk of tuberculosis in SLE patients from an Asian tertiary hospital
Authors: Yang Y, Thumboo J, Tan BH, Tan TT, Fong CHJ, Ng HS, Fong KY
Year: 2017
Citation: Rheumatol Int. 37(6): 1027–1033

Title: Delays in diagnosis and treatment of pulmonary tuberculosis in AFB smear-negative patients with pneumonia
Authors: Zhang ZX, Sng LH, Yong Y, Lin LM, Cheng TW, Seong NH, Yong FK
Year: 2017
Citation: Int J Tuberc Lung Dis. doi: 10.5588/ijtld.16.0667. [Epub ahead of print]

Title: The effect of chronic liver disease on venous thromboembolism among medically managed patients in Singapore General Hospital
Authors: Yang Y, Zhang XZ, Ng HS, Fong CHJ, Lee LH
Year: 2015
Citation: Thrombosis Research. 136: 548–551

Title: The effect of comorbidity on hospital mortality in patients with SLE from an Asian tertiary hospital
Authors: Yang Y, Julian T, Arul E, Yong SL, Fong KY
Year: 2014
Citation: Lupus. 23: 714–720

Title: 新加坡中央医院针灸门诊的规范化管理
Authors: Cui S, Tan K, Ong BC, Huang Y, Yang Y, Xu S, Ng HS
Year: 2014
Citation: Chinese Acupuncture and Moxibustion. 34(2): 179–182

Title: The Effect of a Brief Low-Intensity Therapeutic Lifestyle Counselling Intervention on Weight Loss among Overweight in Primary Care: a Pilot Randomised Controlled Trial
Authors: Ng Lee Beng, Yang Yong, Koh Choon-Huat Gerald
Year: 2014
Citation: Proceedings of Singapore Healthcare. 23(2): 118–125

Title: Applicability of a previously validated readmission predictive index in medical patients in Singapore: a retrospective study
Authors: Tan SY, Low LL, Yang Y, Lee KH
Year: 2013
Citation: BMC Health Services Research. 13: 366

Title: Safety Culture in Acupuncture Practice in a Tertiary Hospital-The Singapore General Hospital Experience
Authors: Cui S, Tan K, Subner SH, Xu P, Lim S, Huang Y, Yang Y, Xu S, Ng HS
Year: 2013
Citation: Med Acupunct. 25(1): 61–73

Title: The burden of diabetes mellitus in elderly patients from an Asian tertiary hospital
Authors: Yang Y, Goh SY, Tan SB, Ho H, Emmanuel S, Wang P, Ng HS
Year: 2012
Citation: Eur J Intern Med. 23: e1–e4

Title: Risk factors for lower extremity amputation among patients with diabetes in Singapore
Authors: Yang Y, Østbye T, Tan SB, Ong BC, Abdul-Salam ZH, Yang KS
Year: 2011
Citation: J Diabetes Complications. 25: 382–386

Title: Clinical characteristics and outcomes of hospitalized patients with 2009 H1N1 influenza in a large, acute-care tertiary hospital in Singapore
Authors: Hsann YM, Abdul-Salam ZH, Lim V, Yang Y, Yang KS
Year: 2011
Citation: Am J Infect Cont. 39(8): e49–51

Title: Respiratory dysfunction in sepsis patients – the protective effect of diabetes mellitus
Authors: Yang Y, Abdul-Salam ZH, Ong BC, Yang KS
Year: 2011
Citation: Am J Crit Care. 20: e41–e47

Title: Bringing generalists into the hospital: outcomes of a family medicine hospitalists model in Singapore
Authors: Hock Lee K, Yang Y, Soong Yang K, Chi Ong B, Seong Ng H
Year: 2011
Citation: J Hosp Med. 6(3): 115–121. doi: 10.1002/jhm.821

Title: The effect of comorbidity and age on hospital mortality and length of stay in patients with sepsis
Authors: Yang Y, Yang KS, Hsann YM, Lim V, Ong BC
Year: 2010
Citation: J Crit Care. 25(3): 398–405. Epub 2009 Oct 15

Title: Objective assessment of facial lipoatrophy changes in a cohort of HIV infected patients taking combination antiretroviral therapy
Authors: Yang Y, Yap M, Oo Tha N, Paton NI
Year: 2008
Citation: HIV Clinical Trials. 9(6): 399–406

Title: Changes in facial fat in lipodystrophy, wasting and weight gain measured by magnetic resonance imaging
Authors: Paton NI, Yang Y, Oo Tha N, Sitoh YY
Year: 2007
Citation: HIV Clinical Trials. 8(4): 227–234

Title: Validation of 3-dimensional laser scanning for the assessment of facial fat changes
Authors: Paton NI, Yang Y, Oo Tha N
Year: 2007
Citation: HIV Med. 8(8): 498–503

Conclusion

In conclusion, Dr. Yang Yong is an outstanding researcher and leader whose career exemplifies dedication to advancing medical science, healthcare quality, and public health. His strong educational background, vast professional experience, and impactful research on infectious diseases, epidemiology, and chronic health conditions reflect a lifelong commitment to improving patient care and medical knowledge. His numerous publications in high-impact journals, research grants, and recognition through academic awards highlight his contributions to global healthcare challenges. Moreover, his role in mentoring young researchers and serving in leadership positions demonstrates his influence in shaping future generations of scientists. With proven expertise, a global outlook, and a vision for improving healthcare systems, Dr. Yang is highly deserving of recognition and stands out as an exemplary candidate for the Best Researcher Award.

Iraj Alipourfard | Biomedical Sciences | Best Researcher Award

Dr. Iraj Alipourfard | Biomedical Sciences | Best Researcher Award 

Researcher, at Institute of Physical Chemistry Polish Academy of Sciences, Poland.

Summary

Dr. Iraj Alipourfard is a distinguished researcher and educator specializing in biomedical sciences, nanotechnology, and tissue engineering. Currently serving as a Postdoctoral Research Associate at the Institute of Physical Chemistry, Polish Academy of Sciences, he contributes to groundbreaking projects in organ-on-chip systems, regenerative therapy, and nanoparticle applications. With over 20 years of experience in academia and clinical practice, Dr. Alipourfard has lectured in biochemistry, molecular biology, and pharmacology across institutions in Iran, Armenia, and Poland. His multidisciplinary expertise spans cell encapsulation, microfluidics, and advanced molecular diagnostics. A prolific author and reviewer, he is also a martial arts champion with a black belt in judo.

Professional Profile

Scopus

Google Scholar

ORCID

Education

🎓 Dr. Alipourfard holds a Master of Science in Medical Analytic Laboratory Sciences from Tehran University of Medical Sciences (2005), where his thesis explored genetic disruptions in Saccharomyces cerevisiae. He completed a postdoctoral training in Clinical Biochemistry at Iran University of Medical Sciences (2022). Additionally, he earned a Postgraduate Diploma in Nutrition from the University of Vocational Education, Poland (2022). His academic foundation integrates biomedical research with applied clinical diagnostics, preparing him for interdisciplinary innovations in biomedicine.

Experience

🧪 Dr. Alipourfard is currently a Postdoctoral Research Associate at the Institute of Physical Chemistry, Polish Academy of Sciences. His work involves developing microfluidics-assisted 3D cell cultures and encapsulated pancreatic hydrogels for regenerative therapies. Previously, he was a University Research Assistant at the University of Silesia, investigating gut microbiota’s role in diabetes. He also lectured in biochemistry and genetics at Yerevan Haybusak University and managed medical laboratories at hospitals in Iran. His expertise in biomedical laboratory techniques and academic instruction has been a cornerstone of his career.

Research Interests

🔬 Dr. Alipourfard’s research interests center on regenerative medicine, nanobiotechnology, and tissue engineering. He focuses on microfluidic systems for T-regulatory lymphocyte encapsulation, anti-bacteriophage nanoparticle synthesis, and organoid modeling for drug sensitivity assays. His work also explores the interplay of gut microbiota in diabetes and obesity. Passionate about translational science, Dr. Alipourfard aims to bridge the gap between bench research and clinical applications, especially in autoimmune therapy and cancer diagnostics.

Awards

🏆 Dr. Alipourfard’s accolades include the LazioDisco Italian Governmental Scholarship (2016–2018), the Erasmus Internship Award (2018–2019), and the Best Presentation Award at a Clinical Microbiology Conference in Shiraz, Iran. He also secured the First Ranking Position in the admission test for the Master of Pharmacy program at the University of Rome Tor Vergata. His diverse honors reflect his academic excellence, international collaborations, and impactful contributions to biomedical sciences.

Top Noted Publications

📚 Dr. Alipourfard has authored 65 scientific articles, two book chapters on cancer and nanotechnology, and numerous conference papers. Below are selected publications with hyperlinks:

  • “The Role of Akt Protein Kinase in Metabolic-Inflammatory Pathways Cross-Talk”
    Published in: Journal of Biochemistry, 2019

    • Cited by: 150 articles
    • This study investigates the interaction between Akt protein kinase and metabolic-inflammatory pathways, with an emphasis on how TNF-α regulation can improve insulin resistance in HepG2 cells. The research contributes to understanding the role of Akt in managing metabolic disorders.
  • “Molecular Evaluation of Methicillin-Resistant Staphylococcus aureus”
    Published in: Clinical Microbiology & Infection, 2010

    • Cited by: 300 articles
    • This article presents an in-depth molecular analysis of methicillin-resistant Staphylococcus aureus (MRSA), focusing on its genetic and antimicrobial resistance profiles. The findings provide significant insights into the epidemiology and molecular mechanisms of MRSA in healthcare settings.
  • “Nanomedicine: A New Frontier of Nanotechnology in Clinical Practice”
    Published in: Advanced Research in Physics Conference Proceedings, 2009

    • This paper explores the potential applications of nanomedicine, highlighting the transformative role of nanotechnology in diagnosing and treating diseases. The work sheds light on how nanomedicine could revolutionize clinical practices, enhancing therapeutic delivery and diagnostic capabilities.

Conclusion

Iraj Alipourfard is a highly qualified researcher with a robust portfolio of innovative research, practical applications, and academic teaching. His impressive list of awards, publications, and ongoing research projects positions him as an ideal candidate for the Best Researcher Award. With continued interdisciplinary collaboration and expansion of his research influence, he is poised to make even greater contributions to the scientific community.